Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
American Journal of Clinical Pathology|May 19, 2005
Bimodal cell populations are common in chronic lymphocytic leukemia but do not impact overall survivalAmy E Cocco, Ebenezer S Osei, Dawn M Thut, et al.American Journal of Clinical Pathology|March 13, 2021
Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative DisordersAudrey N Jajosky, Nathaniel P Havens, Navid Sadri, et al.The Journal of Urology|June 7, 2002
Follicular large cell lymphoma localized to the testis in childrenKourosh Pakzad, Gregory T MacLennan, Jack S Elder, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2012
Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processingDaimon P Simmons, Pamela A Wearsch, David H Canaday, et al.European Journal of Haematology|January 2, 2021
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasiaAudrey N Jajosky, Navid Sadri, Howard J Meyerson, et al.Biorxiv : the Preprint Server for Biology|June 4, 2025
Role of channels in the O<sub>2</sub> permeability of murine red blood cells II. Morphological and proteomic studiesFraser J Moss, Pan Zhao, Ahlam I Salameh, et al.Therapeutic Advances in Allergy and Rhinology|September 14, 2023
CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of <i>MAGT1</i> DeficiencyMarija J Rowane, Benjamin C Stewart-Bates, Rayna J Doll, et al.Transplantation|November 30, 2005
Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantationThomas O Kleen, Suzanne Kadereit, Laura R Fanning, et al.Journal of the American Academy of Dermatology|May 27, 2009
A case of recurrent pseudolymphomatous folliculitis: A mimic of cutaneous lymphomaEun Ji Kwon, Arni K Kristjansson, Howard J Meyerson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemiaBrenda W Cooper, Gareth J Veal, Tomas Radivoyevitch, et al.Pageof 5